Nurse Practitioner · Opelousas, LA
NPI
1063419745
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
3975 I 49 S Service Rd, 234
Opelousas, LA, 70570
Phone (337) 942-8694
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,312
268 services
Medicare patients, 2024
74
Average age 67
Drug cost, 2024
$1.1M
23,675 prescriptions
Company payments, 2025
$657
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jimmy Legros III was code 99214 (office e&m - established), 86 times for 70 patients. In total Jimmy Legros III billed 268 services in 12 codes, and Medicare paid $3,312.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 86 | 70 | $32.63 | $2,806 |
| 96372 Injection Administration | Office | 26 | 14 | $3.69 | $96.03 |
By year: 2022 $59K for 2,237 services; 2023 $47K for 2,243 services; 2024 $3,312 for 268 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 60 | 37 | $9.36 | $562 |
| 36415 Venipuncture Blood Collection | 37 | 34 | $4.90 | $181 |
| 81002 Clinical Chemistry | 11 | 11 | $3.41 | $37.51 |
Medicare prescription drug claims, 2024
In 2024, the drug Jimmy Legros III prescribed most often to Medicare patients was Montelukast Sodium, with 844 prescriptions and refills. In total Jimmy Legros III wrote 23,675 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 844 | 1,004 | 182 | $3,781 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 824 | 844 | 168 | $16K |
| Gabapentin Generic | 793 | 817 | 127 | $8,813 |
| Amlodipine Besylate Generic | 746 | 973 | 124 | $2,197 |
| Alprazolam Generic | 672 | 673 | 80 | $2,040 |
| Hydrochlorothiazide Generic | 508 | 656 | 88 | $1,686 |
| Simvastatin Generic | 502 | 618 | 77 | $2,189 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 498 | 498 | 84 | $3,332 |
| Ibuprofen Generic | 498 | 500 | 92 | $6,204 |
| Levothyroxine Sodium Generic | 495 | 618 | 72 | $2,718 |
| Omeprazole Generic | 472 | 602 | 77 | $3,661 |
| Baclofen Generic | 469 | 528 | 91 | $2,632 |
| Metformin Hcl Generic | 416 | 567 | 70 | $1,582 |
| Atorvastatin Calcium Generic | 394 | 566 | 66 | $1,480 |
| Lisinopril Generic | 387 | 575 | 70 | $1,390 |
Brand drugs: 2,154 claims; generic drugs: 21,381 claims; opioid claims: 779.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jimmy Legros III $657 ($657 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $203.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $158 |
| Abbvie Inc. ABBV | 3 | $57.33 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $56.94 |
| Axsome Therapeutics, Inc. AXSM | 2 | $44.3 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $43.78 |
| Valinor Pharma, LLC | 3 | $43.52 |
| Amgen Inc. AMGN | 1 | $18.83 |
| GlaxoSmithKline, LLC. GSK | 1 | $17.22 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $14.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.